Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

375680 Hesperadin - CAS 422513-13-1 - Calbiochem

Hesperadin primarily used in Inhibition.

Hesperadin - CAS 422513-13-1 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Mammalian Ste20-like Kinase 4 Inhibitor, MST4 Inhibitor, Aurora Kinase Inhibitor X, AMPK Inhibitor II

375680
Purchase on Sigma-Aldrich

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
422513-13-1C₂₉H₃₂N₄O₃S

Products

RéférenceConditionnement Qté
375680-5MG Flacon en verre 5 mg
Description
OverviewA cell-permeable indolinone compound that interacts with both the ATP- and the adjacent hydrophobic binding pocket of Aurora B and acts as a rapid and reversible inhibitor of Aurora kinase B activity (IC50 ~ 250 nM) with moderate selectivity over Cdk1/B, Cdk2/E and Cdk4/D1 (IC50 = 1.2, > 10 and > 10 µM). Also, potently inhibits several kinases at 1 µM in a 25-kinase screening panel (100%, 100%, 96%, 88%, 87% and 84% against Lck, PHK, AMPK, MKK1, MAPKAP-K1 and Chk1, respectively). Reported to reduce histone H3-Ser10 phosphorylation, inhibit cytokinesis, promote chromosome biorientation, perturb mitosis and polyploidy in mammalian cells. Recently shown to potently inhibit MST4 kinase (IC50 = 6.18 nM) in an ATP-competitive manner. Dose-dependently accelerates hypoxia-induced apoptosis and decreases survival (EC50 = 10 nM in MST4 LβT2 gonadotrope cells).
Catalogue Number375680
Brand Family Calbiochem®
SynonymsMammalian Ste20-like Kinase 4 Inhibitor, MST4 Inhibitor, Aurora Kinase Inhibitor X, AMPK Inhibitor II
References
ReferencesXiong, W., et al. 2016. Mol. Cancer Ther. 15, In press.
Knowlton, A.L., et al. 2006. Curr. Biol. 16, 1705.
Kapoor, T.M., et al. 2006. Science 311, 388.
Hirota, T., et al. 2005. Nature 438, 1176.
Sessa, F., et al. 2005. Mol. Cell. 18, 379.
Lampson, M.A., et al. 2004. Nat. Cell Biol. 6, 232.
Hauf, S., et al. 2003. J. Cell Biol. 161, 281.
Product Information
CAS number422513-13-1
FormYellow solid
Hill FormulaC₂₉H₃₂N₄O₃S
Chemical formulaC₂₉H₃₂N₄O₃S
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Regulatory Review
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot freeze at -(20°C). Stock solutions are stable for up to 6 months at -20°C..
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
375680-5MG 04055977212945

Documentation

Hesperadin - CAS 422513-13-1 - Calbiochem FDS

Titre

Fiche de données de sécurité des matériaux (FDS) 

Hesperadin - CAS 422513-13-1 - Calbiochem Certificats d'analyse

TitreNuméro de lot
375680

Références bibliographiques

Aperçu de la référence bibliographique
Xiong, W., et al. 2016. Mol. Cancer Ther. 15, In press.
Knowlton, A.L., et al. 2006. Curr. Biol. 16, 1705.
Kapoor, T.M., et al. 2006. Science 311, 388.
Hirota, T., et al. 2005. Nature 438, 1176.
Sessa, F., et al. 2005. Mol. Cell. 18, 379.
Lampson, M.A., et al. 2004. Nat. Cell Biol. 6, 232.
Hauf, S., et al. 2003. J. Cell Biol. 161, 281.
Fiche technique

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision31-August-2011 RFH
SynonymsMammalian Ste20-like Kinase 4 Inhibitor, MST4 Inhibitor, Aurora Kinase Inhibitor X, AMPK Inhibitor II
DescriptionA cell-permeable indolinone compound that interacts with both the ATP- and the adjacent hydrophobic binding pocket of Aurora B and acts as a rapid and reversible inhibitor of Aurora kinase B activity (IC50 ~250 nM) with moderate selectivity over Cdk1/B, Cdk2/E and Cdk4/D1 (IC50 = 1.2, > 10 and > 10 µM). Also, potently inhibits several kinases at 1 µM in a 25-kinase screening panel (100%, 100%, 96%, 88%, 87% and 84% against Lck, PHK, AMPK, MKK1, MAPKAP-K1 and Chk1, respectively). Reported to reduce histone H3-Ser10 phosphorylation, inhibit cytokinesis, promote chromosome biorientation, perturb mitosis and polyploidy in mammalian cells.
FormYellow solid
Intert gas (Yes/No) Packaged under inert gas
CAS number422513-13-1
Chemical formulaC₂₉H₃₂N₄O₃S
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (50 mg/ml)
Storage Protect from light
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot freeze at -(20°C). Stock solutions are stable for up to 6 months at -20°C..
Toxicity Regulatory Review
ReferencesXiong, W., et al. 2016. Mol. Cancer Ther. 15, In press.
Knowlton, A.L., et al. 2006. Curr. Biol. 16, 1705.
Kapoor, T.M., et al. 2006. Science 311, 388.
Hirota, T., et al. 2005. Nature 438, 1176.
Sessa, F., et al. 2005. Mol. Cell. 18, 379.
Lampson, M.A., et al. 2004. Nat. Cell Biol. 6, 232.
Hauf, S., et al. 2003. J. Cell Biol. 161, 281.